Skip to main content
. 2016 Nov 29;2016(11):CD012436. doi: 10.1002/14651858.CD012436

NCT00940628.

Methods Type of trial: interventional; randomised control trial
Allocation: randomised
Intervention model: parallel assignment
Masking: open label
Primary purpose: treatment
Participants Condition: obesity
Enrolment: 60
Inclusion criteria:
  • adolescent participants, aged 12 to 14 years

  • overweight or obese


Exclusion criteria:
  • aged < 12 or > 14 years;

  • BMI in normal range

Interventions Intervention: orlistat (Xenical) + diet and exercise programme
Comparator: diet and exercise programme
Outcomes Primary outcome:
  • change in BMI (time frame: at each clinic visit, every 4 weeks)


Secondary outcomes:
  • adverse events

  • laboratory parameters (time frame: at each clinic visit, every 4 weeks


Other outcomes: not reported
Study identifier NCT number: NCT00940628
Other trial ID number: ML19569
Trial start date: April 2008
Trial completion date: September 2010
Official title Open‐label Comparative Randomized Study of the Efficacy and Safety of Orlistat (Xenical) in Complex Therapy of Obesity and Metabolic Disorders in Adolescents
Stated purpose of study Quote: "This 2 arm study will assess the effect of Xenical on body mass index (BMI) in obese or overweight adolescents"
Notes Trial was completed in 2010, no publication is available
The health authority associated with this trial is "Russia: Federal Service on Surveillance in Healthcare and Social Development of RF"